Page last updated: 2024-10-15

3-hydroxykynurenine and Atypical Cluster Headache

3-hydroxykynurenine has been researched along with Atypical Cluster Headache in 1 studies

3-hydroxykynurenine: RN given refers to cpd without isomeric designation
3-hydroxykynurenine : A hydroxykynurenine that is kynurenine substituted by a hydroxy group at position 3.
hydroxykynurenine : A hydroxy-amino acid that is kynurenine substituted by a single hydroxy group at unspecified position. A "closed" class.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Curto, M1
Lionetto, L1
Negro, A1
Capi, M1
Perugino, F1
Fazio, F1
Giamberardino, MA1
Simmaco, M1
Nicoletti, F1
Martelletti, P1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Exploration of the Role of Tryptophan Metabolites in Pediatric Migraine[NCT05969990]200 participants (Anticipated)Observational2022-01-01Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for 3-hydroxykynurenine and Atypical Cluster Headache

ArticleYear
Altered serum levels of kynurenine metabolites in patients affected by cluster headache.
    The journal of headache and pain, 2015, Volume: 17

    Topics: Adult; Cluster Headache; Female; Humans; Hydroxyindoleacetic Acid; Kynurenic Acid; Kynurenine; Male;

2015